Middle East And Africa Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Disease Indication (Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease, Others), By Drug Type (Immunomodulator, Vesicular Monoamine Transporter 2 (VMAT2), Others), By Routes of Administration (Oral, Intravenous (IV) delivery, Others) and By Country (UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Rest of MEA) Forecasts, 2026-2034

Last Updated: August 31, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Middle East And Africa Neurodegenerative Disease Market Size Analysis
    1. Introduction
    2. Middle East And Africa Neurodegenerative Disease Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Multiple Sclerosis
      2. Parkinson's Disease
      3. Alzheimer's Disease
      4. Others
    3. Middle East And Africa Neurodegenerative Disease Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulator
      2. Vesicular Monoamine Transporter 2 (VMAT2)
      3. Others
    4. Middle East And Africa Neurodegenerative Disease Market Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous (IV) delivery
      3. Others
  7. Middle East and Africa Middle East And Africa Neurodegenerative Disease Market Size Analysis
    1. Introduction
    2. Middle East And Africa Neurodegenerative Disease Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Multiple Sclerosis
      2. Parkinson's Disease
      3. Alzheimer's Disease
      4. Others
    3. Middle East And Africa Neurodegenerative Disease Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulator
      2. Vesicular Monoamine Transporter 2 (VMAT2)
      3. Others
    4. Middle East And Africa Neurodegenerative Disease Market Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous (IV) delivery
      3. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
  8. Competitive Landscape
    1. Middle East And Africa Neurodegenerative Disease Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  9. Market Players Assessment
    1. Abbvie Inc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Amneal Pharmaceuticals Inc.
    3. Boehringer Ingelheim International GmbHF
    4. Hoffmann-La Roche
    5. Merck & Co. Inc.
    6. Novartis AG
    7. Pfizer Inc.
    8. Teva Pharmaceuticals Ltd
    9. UCB SA
    10. Biogen Inc
  10. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  11. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  12. Disclaimer

List of Tables

Table 1: Middle East and Africa Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 2: Middle East and Africa Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 3: Middle East and Africa Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 4: Middle East and Africa Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 5: UAE Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 6: UAE Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 7: UAE Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 8: Turkey Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 9: Turkey Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 10: Turkey Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 11: Saudi Arabia Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 12: Saudi Arabia Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 13: Saudi Arabia Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 14: South Africa Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 15: South Africa Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 16: South Africa Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 17: Egypt Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 18: Egypt Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 19: Egypt Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 20: Nigeria Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 21: Nigeria Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 22: Nigeria Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 23: Rest of MEA Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 24: Rest of MEA Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 25: Rest of MEA Middle East And Africa Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

We are featured on: